Antibiotics
Overview
Antibiotics is a peer-reviewed scientific journal that focuses on the discovery, development, and application of antibiotics to combat infectious diseases. It publishes high-quality research articles, reviews, and communications, covering various aspects of antibiotic research, including mechanisms of action, resistance, pharmacokinetics, and clinical trials. The journal serves as a valuable resource for researchers, healthcare professionals, and policymakers in the field of antimicrobial therapy.
Details
Details
Abbr.
Antibiotics (Basel)
Start
2012
End
Continuing
Frequency
Quarterly
e-ISSN
2079-6382
Country
Switzerland
Language
English
Specialty
Pharmacology
Metrics
Metrics
h-index / Ranks: 4576
77
SJR / Ranks: 4344
920
CiteScore / Ranks: 4374
5.50
JIF / Ranks: 1690
4.8
Recent Articles
1.
Roson-Calero N, Lucas J, Gomis-Font M, de Pedro-Jove R, Oliver A, Balleste-Delpierre C, et al.
Antibiotics (Basel)
. 2025 Feb;
14(2).
PMID: 40001456
In the original publication [...].
2.
Swider K, Babicki M, Biesiada A, Suszko M, Mastalerz-Migas A, Kloda K
Antibiotics (Basel)
. 2025 Feb;
14(2).
PMID: 40001455
: Antibiotic resistance is a major public health problem in Europe. Most antibiotics are sold only by prescription in Poland, and it is mainly up to physicians to decide whether...
3.
Cai T, Brugnolli A, Lanzafame M, Dellai F, Tascini C, Scarparo C, et al.
Antibiotics (Basel)
. 2025 Feb;
14(2).
PMID: 40001454
: The management of urinary tract infections (UTIs) has become an increasingly challenging medical intervention. This study explores whether adoption of a precision medicine model could improve the management of...
4.
Granata G, Venditti C, Rotondo C, Dimartino V, DArezzo S, Gallo A, et al.
Antibiotics (Basel)
. 2025 Feb;
14(2).
PMID: 40001453
: Multi-drug-resistant Gram-negative bacteria producing metallo-β-lactamase are an increasing concern. Here, we described three cases of infection due to difficult-to-treat and drug-resistant producing metallo-β-lactamases, which were successfully treated with antibiotic...
5.
Thabit A, Alharbi F, Jawah A, Alghamdi A, Miaji M, Alturki F, et al.
Antibiotics (Basel)
. 2025 Feb;
14(2).
PMID: 40001452
Most surveillance studies in Saudi Arabia have been single-centered or did not use the gold standard broth microdilution (BMD) antimicrobial susceptibility test. This is the first study from Saudi Arabia...
6.
Smit C, Keighley C, Rogers K, Miyakis S, Taxis K, Robertson H, et al.
Antibiotics (Basel)
. 2025 Feb;
14(2).
PMID: 40001451
Methods: A retrospective, longitudinal, and ecological analysis was conducted between 31 May 2016 and 31 December 2018. The primary outcomes were the monthly prevalence of AMR in urine isolates and...
7.
Parvin N, Joo S, Mandal T
Antibiotics (Basel)
. 2025 Feb;
14(2).
PMID: 40001450
The rapid rise of antibiotic resistance has become a global health crisis, necessitating the development of innovative strategies to combat multidrug-resistant (MDR) pathogens. Nanomaterials have emerged as promising tools in...
8.
Ortega-Paredes D, Del Canto F, Rios R, Diaz L, Reyes J, Arias C, et al.
Antibiotics (Basel)
. 2025 Feb;
14(2).
PMID: 40001449
() and () are resistant to third-generation cephalosporins (3GCs), carbapenems, colistin, and tigecycline, making them a major public health priority, mainly within the developing world. However, their genomic epidemiology and...
9.
Mederake M, Hofmann U, Eleftherakis G
Antibiotics (Basel)
. 2025 Feb;
14(2).
PMID: 40001448
: Periprosthetic joint infections (PJIs) are feared complications in arthroplasty and are associated with an increased mortality rate. PJI prevention is of paramount importance since treatment is difficult. In case...
10.
Annisa N, Afifah N, Santoso P, Yunivita V, Te Brake L, Aarnoutse R, et al.
Antibiotics (Basel)
. 2025 Feb;
14(2).
PMID: 40001447
: Studies show that SNPs in rs2032582 and rs4149015 affect the PK profile of moxifloxacin, a key drug for MDR-TB. This study aimed to assess the genotype frequencies of rs2032582...